ORUKA

Serial Number 98649557
688

Registration Progress

Application Filed
Jul 15, 2024
Under Examination
Jun 17, 2025
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 17, 2025 147 days

Trademark Image

ORUKA

Basic Information

Serial Number
98649557
Filing Date
July 15, 2024
Published for Opposition
April 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jun 17, 2025
Application
Pending
Classes
001 005 042

Rights Holder

Oruka Therapeutics, Inc.

03
Address
855 Oak Grove Ave., Suite 100
Menlo Park, CA 94025

Ownership History

Oruka Therapeutics, Inc.

Original Applicant
03
Menlo Park, CA

Oruka Therapeutics, Inc.

Owner at Publication
03
Menlo Park, CA

Legal Representation

Attorney
Nichole T. Hayden

USPTO Deadlines

Next Deadline
147 days remaining
NOA E-Mailed - SOU Required
Due Date
December 17, 2025
Extension Available
Until June 17, 2026

Application History

14 events
Date Code Type Description Documents
Jun 17, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 27, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 26, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 26, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 26, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 14, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 14, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 14, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 31, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 15, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 15, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biochemical preparations for scientific purposes, namely, in vitro scientific or research use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Class 005
Biologics in the nature of pharmaceutical preparations for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Antibodies for medical purposes, namely, for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Therapeutic pharmaceutical for the treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications
Class 042
Biotechnology research related to antibodies and therapies for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications

Classification

International Classes
001 005 042